2013 GI Conference: AT13387, A Novel Non-Ansamycin Inhibitor of HSP 90 is Active against GIST

/in , ,

2013 GI Conference: AT13387, A Novel Non-Ansamycin Inhibitor of HSP 90 is Active against GIST

2013 AACR: AT-IAP, a dual cIAP1 and XIAP antagonist with oral antitumor activity in melanoma models

/in , ,

2013 AACR: AT-IAP, a dual cIAP1 and XIAP antagonist with oral antitumor activity in melanoma models

2012 EORTC: Activity of the HSP90 inhibitor AT13387 in ALK-driven tumor models

/in , ,

2012 EORTC: Activity of the HSP90 inhibitor AT13387 in ALK-driven tumor models

2012 Apoptosis and Cancer: A Potent XIAP And cIAP1 Dual Antagonist Is Effective In Melanoma Models

/in , ,

2012 Apoptosis and Cancer: A Potent XIAP And cIAP1 Dual Antagonist Is Effective In Melanoma Models

2012 EORTC: SGI-110 enhances sorafenib activity and alters methylation signature of HCC Cell lines

/in , ,

2012 EORTC: SGI-110 enhances sorafenib activity and alters methylation signature of HCC Cell lines

2012 AACR: Chemosensitizing effects of DNA methylation inhibitor SGI-110 in Ovarian Cancer

/in , ,

2012 AACR: Chemosensitizing effects of DNA methylation inhibitor SGI-110 in Ovarian Cancer

2012 AACR: SGI-110, a novel SQ second generation DNA hypomethylating agent

/in , ,

2012 AACR: SGI-110, a novel SQ second generation DNA hypomethylating agent

2012 AACR: Scale up & development of a process for a low volume subcutaneous formulation of SGI-110

/in , ,

2012 AACR: Scale up & development of a process for a low volume subcutaneous formulation of SGI-110

2012 EORTC: Characterization of a Potent XIAP & cIAP1 Dual Antagonist in Melanoma and Leukemia

/in , ,

2012 EORTC: Characterization of a Potent XIAP & cIAP1 Dual Antagonist in Melanoma and Leukemia